Investing NewsNovo Nordisk Boosts Its Guidance on Demand for Its Weight-Loss Drugs, AgainOctober 13, 2023 by admin 0 Comments Novo Nordisk raised its full-year outlook again as demand soars for its Ozempic and Wegovy weight-loss treatments. Articles You May Like 3 Smart Stocks to Buy for $500 to Accelerate Your Wealth Growth 3 Smart Stocks to Buy for $500 to Accelerate Your Wealth Growth Buffett’s Billion-Dollar Biz: 3 Crucial Takeaways From Berkshire’s Q1 Results Operating Cash Flow vs. Net Income: What’s the Difference? Countries with the Highest Single and Family Income Tax Rates 3 Stocks to Buy Now as Jobs Data Spurs Market Optimism